These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 16391877

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma.
    Zhou L, Feng X, Shan W, Zhou W, Liu W, Wang L, Zhu B, Yi H, Yao K, Ren C.
    Oncology; 2007; 72(5-6):357-63. PubMed ID: 18187958
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
    Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM, Johnson PJ.
    Cancer Res; 1999 Jan 01; 59(1):71-3. PubMed ID: 9892188
    [Abstract] [Full Text] [Related]

  • 46. ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis.
    Huang J, Lin Y, Li L, Qing D, Teng XM, Zhang YL, Hu X, Hu Y, Yang P, Han ZG.
    Mol Carcinog; 2009 Feb 01; 48(2):130-40. PubMed ID: 18612997
    [Abstract] [Full Text] [Related]

  • 47. [Research on promoter region methylation status of tumor repressor gene P16 in human hepatocellular carcinoma by using methylation sensitive restriction enzyme and semi-nested PCR assay].
    Jiang L, Qin Y, Sun ZL, Sun ZF, Wang JH, Yang LC.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan 01; 38(1):53-6. PubMed ID: 17294727
    [Abstract] [Full Text] [Related]

  • 48. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
    Tang SH, Yang DH, Huang W, Zhou HK, Lu XH, Ye G.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4171-7. PubMed ID: 16857788
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas.
    Jin J, You H, Yu B, Deng Y, Tang N, Yao G, Shu H, Yang S, Qin W.
    Biochem Biophys Res Commun; 2009 Jan 30; 379(1):86-91. PubMed ID: 19100240
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Impact of p16INK4A and p15INK4B on human hepatocellular carcinoma cell proliferation and apoptosis].
    Qin Y, Liu JY, Li B, Peng WZ, Fu MD, Sun ZL, Sun ZF.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr 30; 21(2):132-7. PubMed ID: 15079795
    [Abstract] [Full Text] [Related]

  • 54. Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma.
    Yao D, Jiang D, Huang Z, Lu J, Tao Q, Yu Z, Meng X.
    Cancer; 2000 Feb 15; 88(4):761-9. PubMed ID: 10679644
    [Abstract] [Full Text] [Related]

  • 55. Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma.
    Jicai Z, Zongtao Y, Jun L, Haiping L, Jianmin W, Lihua H.
    Mol Carcinog; 2006 Jul 15; 45(7):530-6. PubMed ID: 16649250
    [Abstract] [Full Text] [Related]

  • 56. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan.
    Chen SC, Lin CY, Chen YH, Fang HY, Cheng CY, Chang CW, Chen RA, Tai HL, Lee CH, Chou MC, Lin TS, Hsu LS.
    Oncol Rep; 2006 Jan 15; 15(1):167-72. PubMed ID: 16328051
    [Abstract] [Full Text] [Related]

  • 57. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.
    Zhao W, Liu H, Liu W, Wu Y, Chen W, Jiang B, Zhou Y, Xue R, Luo C, Wang L, Jiang JD, Liu J.
    Int J Oncol; 2006 May 15; 28(5):1081-8. PubMed ID: 16596223
    [Abstract] [Full Text] [Related]

  • 58. Aberrant methylation of the CHFR gene in advanced hepatocellular carcinoma.
    Sakai M, Hibi K, Kanazumi N, Nomoto S, Inoue S, Takeda S, Nakao A.
    Hepatogastroenterology; 2005 May 15; 52(66):1854-7. PubMed ID: 16334792
    [Abstract] [Full Text] [Related]

  • 59. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA.
    Zhang YJ, Wu HC, Shen J, Ahsan H, Tsai WY, Yang HI, Wang LY, Chen SY, Chen CJ, Santella RM.
    Clin Cancer Res; 2007 Apr 15; 13(8):2378-84. PubMed ID: 17438096
    [Abstract] [Full Text] [Related]

  • 60. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R, Li BZ, Ling YQ, Zhang HP, Li H, Liu Y, Hu XQ, Zhu HG.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 15; 29(3):166-70. PubMed ID: 17649629
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.